Related Experiment Video
Updated: Apr 6, 2026

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Erythema multiforme associated with zonisamide in a dog
Amanda L Ackermann1, Linda A Frank1, Michael F McEntee2
1Department of Small Animal Clinical Sciences, University of Tennessee, 2407 River Drive, Knoxville, TN, 37996, USA.
A dog experienced erythema multiforme after receiving the anticonvulsant zonisamide. This adverse drug reaction is linked to sulphonamides, requiring caution in hypersensitive dogs.
Area of Science:
- Veterinary Dermatology
- Pharmacology
Background:
- Anticonvulsant medications are frequently prescribed for canine epilepsy.
- Sulphonamide-based drugs are known to cause various adverse reactions in dogs.
Observation:
- A canine patient developed erythema multiforme.
- The onset of erythema multiforme was temporally associated with the administration of zonisamide, a sulphonamide-based anticonvulsant.
Findings:
- The case suggests a potential link between zonisamide administration and the development of erythema multiforme in dogs.
- This reaction mirrors adverse effects seen with other sulphonamide drugs.
Implications:
- Veterinarians should exercise caution when prescribing zonisamide to dogs with a history of hypersensitivity to sulphonamides.
- Further investigation into the safety profile of zonisamide in dogs is warranted.
More Related Videos
07:10Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies
Published on: February 9, 2024
03:46Author Spotlight: Coproparasitoscopic Examination of Dog Stools for Control and Prevention of Zoonotic Parasite Diseases
Published on: December 15, 2023
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drug Toxicity: Allergic Reactions
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Hypersensitivity Reactions: Immune-Complex Reactions
Myocarditis II: Clinical Features and Diagnostic Tests